-
4,4′-(1,3-Phenylenedioxy) dianiline 2479-46-1
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Khoom siv chemistry |Polyimide monomers |
4,4′-(1,3-Phenylenedioxy) dianiline|CAS: 2479-46-1 |C18H16N2O2
-
4,4′-(4,4′-Isopropylidedeniphenyl-1,1′-diyldioxy) dianiline 13080-86-9
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Muaj Khoom Siv Tshuaj Kho Mob |Polyimide monomers |4,4′-(4,4′-Isopropylidedeniphenyl-1,1′-diyldioxy) dianiline |CAS: 13080-86-9C27H26N2O2
-
(S)-3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester 109010-60-8
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Kab mob plawv |Ntshav siab |S-ATBA |CAS: 109010-60-8 |C16H22N2O3
-
(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate 1423058-53-0
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Cov kab mob Neurological |Tshuaj tua kab mob |(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate |CAS: 1423058-53-0 |C15H22N2O8
-
Lacosamide 175481-36-4
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Cov kab mob Neurological |Tshuaj tua kab mob |Lacosamide |CAS: 175481-36-4 |C13H18N2O3
-
4-(2-Dimethylamino) ethoxybenzylamine 20059-73-8
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Industrial API |digestive system tshuaj |Itopride hydrochloride thiab nws cov Intermediates |4-(2-Dimethylamino) ethoxybenzylamine |CAS: 20059-73-8 |C11H18N2O
-
Ib 122898-67-3
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Industrial API |digestive system tshuaj |Itopride hydrochloride thiab nws cov Intermediates |Itopride |CAS: 122898-67-3 |C20H26N2O4
-
2- (2-Ethoxyphenoxy) ethyl bromide 3259-03-8
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Industrial API |Prostatic Hyperplasia Tshuaj |Tamsulosin Hydrochloride Intermediates |CAS: 3259-03-8 |C10H13BrO2
-
5-Acetonyl-2-methoxybenzene sulfonamide 116091-63-5
Kev tsim khoom thiab muab biopharmaceutical |Raw Khoom |Pharmaceutical Intermediates Reagents |Industrial API |Prostatic Hyperplasia Tshuaj |Tamsulosin Hydrochloride Intermediates |CAS: 116091-63-5 |C10H13NO4S
-
4-(4-Phenylbutoxy) benzoic acid 30131-16-9
Kev tsim khoom thiab muab biopharmaceutical |Pharmaceutical Intermediates Reagents |Cov ntaub ntawv raw |Kab mob ua pa |Pranlukast Intermediates |4-(4-Phenylbutoxy) benzoic acid |CAS: 30131-16-9C17H18O3
-
![3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1](https://www.yisunbio.com/uploads/50.jpg)
3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1
Kev tsim khoom thiab muab biopharmaceutical |Pharmaceutical Intermediates Reagents |Cov ntaub ntawv raw |Kab mob ua pa |Pranlukast Intermediates |3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone |CAS: 136450-06-1 |C25H25NO4
-
3′-Amino-2′-hydroxyacetophenone 70977-72-9
Kev tsim khoom thiab muab biopharmaceutical |Pharmaceutical Intermediates Reagents |Cov ntaub ntawv raw |Kab mob ua pa |Pranlukast Intermediates |3′-Amino-2′-hydroxyacetophenone |CAS: 70977-72-9C8H9 NPO 2